These observations underscore the complexity of EPHA2’s role in liver pathophysiology and highlight the need for further studies to dissect its tissue-specific functions and regulatory mechanisms in MASLD. This evidence concerns the gene EPHA2 and metabolic dysfunction-associated steatotic liver disease.